Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function
Shuzhong Zhang, Chandra L. Shrestha, Benjamin T. Kopp
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 89

Showing 26-50 of 89 citing articles:

Functional and metabolic impairment in cigarette smoke-exposed macrophages is tied to oxidative stress
Daniel Aridgides, Diane Mellinger, David A. Armstrong, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 40
Autophagy Augmentation to Alleviate Immune Response Dysfunction, and Resolve Respiratory and COVID-19 Exacerbations
Garrett Pehote, Neeraj Vij
Cells (2020) Vol. 9, Iss. 9, pp. 1952-1952
Open Access | Times Cited: 34
Respiratory Infection and Inflammation in Cystic Fibrosis: A Dynamic Interplay among the Host, Microbes, and Environment for the Ages
Christiaan Yu, Tom Kotsimbos
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4052-4052
Open Access | Times Cited: 12
Longitudinal Study on Clinical Predictors for Allergic Bronchopulmonary Aspergillosis in Children and Young People with Cystic Fibrosis Highlights the Impact of Infection with Aspergillus and Pseudomonas and Ivacaftor Treatment
Emily Chesshyre, Beth Enderby, Angela C. Shore, et al.
Journal of Fungi (2025) Vol. 11, Iss. 2, pp. 116-116
Open Access
Phosphatidylinositol 5-Phosphate-Loaded Apoptotic Body-Like Liposomes for Mycobacterium abscessus Infection Management in Patients With Cystic Fibrosis
Tommaso Olimpieri, Noemi Poerio, Fabio Saliu, et al.
The Journal of Infectious Diseases (2025)
Closed Access
Targeting the Heme Oxygenase 1/Carbon Monoxide Pathway to Resolve Lung Hyper-Inflammation and Restore a Regulated Immune Response in Cystic Fibrosis
Caterina Di Pietro, Hasan Halit Öz, Thomas S. Murray, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 30
Altered iron metabolism in cystic fibrosis macrophages: the impact of CFTR modulators and implications for Pseudomonas aeruginosa survival
Haley F. Hazlett, Thomas H. Hampton, Daniel Aridgides, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 28
Loss of endothelial CFTR drives barrier failure and edema formation in lung infection and can be targeted by CFTR potentiation
Lasti Erfinanda, Lin Zou, Birgitt Gutbier, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 674
Closed Access | Times Cited: 17
Comparative effects of CFTR modulators on phagocytic, metabolic and inflammatory profiles of CF and nonCF macrophages
Daniel Aridgides, Diane Mellinger, L. Gwilt, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Multimodal analysis of granulocytes, monocytes, and platelets in patients with cystic fibrosis before and after Elexacaftor–Tezacaftor–Ivacaftor treatment
Hanna Schmidt, Larissa Melina Höpfer, Lisa Wohlgemuth, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis
Katherine B. Hisert, Timothy P. Birkland, Kelly Q. Schoenfelt, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 27
Macrophage dysfunction in cystic fibrosis: Nature or nurture?
Keren B. Turton, Rebecca J. Ingram, Miguel A. Valvano
Journal of Leukocyte Biology (2020) Vol. 109, Iss. 3, pp. 573-582
Open Access | Times Cited: 25
Targeting cystic fibrosis inflammation in the age of CFTR modulators: focus on macrophages
Jonathan L. Gillan, Donald J. Davidson, Robert D. Gray
European Respiratory Journal (2020) Vol. 57, Iss. 6, pp. 2003502-2003502
Open Access | Times Cited: 24
The Distribution and Role of the CFTR Protein in the Intracellular Compartments
Agnieszka Łukasiak, Mirosław Zając
Membranes (2021) Vol. 11, Iss. 11, pp. 804-804
Open Access | Times Cited: 23
Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches
Alessandra Ghigo, Giulia Prono, Elisa Riccardi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1952-1952
Open Access | Times Cited: 22
CF Fungal Disease in the Age of CFTR Modulators
Amelia Bercusson, G.A. Jarvis, Anand Shah
Mycopathologia (2021) Vol. 186, Iss. 5, pp. 655-664
Open Access | Times Cited: 22
CFTR Modulators Restore Acidification of Autophago-Lysosomes and Bacterial Clearance in Cystic Fibrosis Macrophages
Asmaa Badr, Mostafa Eltobgy, Kathrin Krause, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 15
Overview of CF lung pathophysiology
Giulio Cabrini, Alessandro Rimessi, Monica Borgatti, et al.
Current Opinion in Pharmacology (2022) Vol. 64, pp. 102214-102214
Closed Access | Times Cited: 15
Impact of CFTR Modulators on the Impaired Function of Phagocytes in Cystic Fibrosis Lung Disease
Aniello Meoli, Olaf Eickmeier, Giovanna Pisi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12421-12421
Open Access | Times Cited: 15
Cystic Fibrosis Bone Disease: The Interplay between CFTR Dysfunction and Chronic Inflammation
Óscar Fonseca, Maria Salomé Gomes, Adelina Amorim, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 425-425
Open Access | Times Cited: 8
An Intriguing Involvement of Mitochondria in Cystic Fibrosis
Maria Favia, Lidia de Bari, Antonella Bobba, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 11, pp. 1890-1890
Open Access | Times Cited: 23
Immunomodulation in Cystic Fibrosis: Why and How?
Vincent D. Giacalone, Brian Dobosh, Amit Gaggar, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3331-3331
Open Access | Times Cited: 21
Emerging Concepts in Defective Macrophage Phagocytosis in Cystic Fibrosis
Devi Jaganathan, Emanuela M. Bruscia, Benjamin T. Kopp
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7750-7750
Open Access | Times Cited: 13
Treatment of Cystic Fibrosis Patients Homozygous for F508del with Lumacaftor-Ivacaftor (Orkambi®) Restores Defective CFTR Channel Function in Circulating Mononuclear Cells
Maria Favia, Crescenzio Gallo, Lorenzo Guerra, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2398-2398
Open Access | Times Cited: 20
(R)-Roscovitine and CFTR modulators enhance killing of multi-drug resistant Burkholderia cenocepacia by cystic fibrosis macrophages
Chandra L. Shrestha, Shuzhong Zhang, B Wisniewski, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 19

Scroll to top